Juvenile Dermatomyositis Magnetic Resonance Imaging Score (JIS) does not correlate with criteria for clinically

Kapil Gargh1, Eslam Al-Abadi2,3, Samantha Low4

  • 1Childhood Arthritis and Rheumatic Diseases Unit, Birmingham Women's and Children's Hospital NHS Foundation Trust, Steelhouse Lane, Birmingham, B4 6NH, West Midlands, UK.

Rheumatology International
|November 19, 2021
PubMed

Insights

The Juvenile Dermatomyositis Imaging Score (JIS) correlates with physician treatment decisions, unlike the PRINTO criteria for clinically inactive disease (CID). MRI findings are crucial for assessing JDM activity and guiding treatment escalation.

Area of Science:

  • Pediatric Rheumatology
  • Medical Imaging
  • Disease Activity Assessment

Background:

  • Current criteria for clinically inactive disease (CID) in Juvenile Dermatomyositis (JDM) do not incorporate Magnetic Resonance Imaging (MRI) findings.
  • The use of MRI and standardized scoring tools for JDM is increasing.
  • There is a need to evaluate the role of MRI in assessing JDM disease activity.

Purpose of the Study:

  • To assess the correlation between MRI scores (using the Juvenile Dermatomyositis Imaging Score - JIS) and clinically inactive disease (CID) criteria.
  • To evaluate the relationship between MRI findings and physician treatment decisions in JDM.
  • To determine if MRI can better predict treatment escalation than current clinical criteria.

Main Methods:

  • Retrospective analysis of MRIs from children with JDM over a 10-year period, scored using the JIS.
  • Collection of demographic, diagnosis, treatment, and core set measures data.
  • Statistical analysis to correlate JIS with CID categories and physician treatment decisions.

Main Results:

  • The JIS was not significantly associated with the CID category but showed a correlation with physician treatment decisions.
  • No significant association was found between clinical decisions and the CID category.
  • The JIS demonstrated good predictive ability for treatment escalation (AUC 0.80), with 78% sensitivity, specificity, and accuracy, outperforming CID criteria.

Conclusions:

  • Clinical criteria alone may be insufficient for accurately assessing JDM disease activity.
  • Physician treatment decisions align with MRI findings, suggesting MRI's utility in clinical practice.
  • Further multi-center prospective studies are required to validate these findings and establish MRI as a reliable biomarker for JDM activity.

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...